CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record.

Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells

Troost, Joachim, Albermann, Nadine, Emil Haefeli, Walter, Weiss, Johanna·2004·Biochemical and Biophysical Research Communications
DOI 10.1016/j.bbrc.2004.02.102
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2004.02.102

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Akiyama, 1985, Isolation and genetic characterization of human KB cell lines resistant to multiple drugs, Somat. Cell Mol. Genet., 11, 117, 10.1007/BF01534700 · DOI
  2. Schinkel, 2003, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview, Adv. Drug Deliv. Rev., 55, 3, 10.1016/S0169-409X(02)00169-2 · DOI
  3. Schinkel, 1994, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 · DOI
  4. van Asperen, 1998, The pharmacological role of P-glycoprotein in the intestinal epithelium, Pharmacol. Res., 37, 429, 10.1006/phrs.1998.0326 · DOI
  5. Kusuhara, 1998, The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs, J. Pharm. Sci., 87, 1025, 10.1021/js970100b · DOI
  6. Chiou, 2000, Potential role of P-glycoprotein in affecting hepatic metabolism of drugs, Pharm. Res., 17, 903, 10.1023/A:1007570517183 · DOI
  7. Gottesman, 2002, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, 2, 48, 10.1038/nrc706 · DOI · Paper page
  8. Lee, 1998, HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter, Biochemistry, 37, 3594, 10.1021/bi972709x · DOI
  9. Back, 1999, Pharmacological issues relating to viral resistance, Infection, 27, S42, 10.1007/BF02561671 · DOI
  10. Romsicki, 2001, Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter, Biochemistry, 40, 6937, 10.1021/bi0024456 · DOI
  11. van Meer, 2002, Cell biology. The different hues of lipid rafts, Science, 296, 855, 10.1126/science.1071491 · DOI
  12. Pohl, 2002, Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line, Biochem. J., 365, 259, 10.1042/bj20011880 · DOI
  13. Lavie, 1998, Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells, J. Biol. Chem., 273, 32380, 10.1074/jbc.273.49.32380 · DOI
  14. Liscovitch, 2000, Multidrug resistance: a role for cholesterol efflux pathways?, Trends Biochem. Sci., 25, 530, 10.1016/S0968-0004(00)01668-6 · DOI
  15. Brown, 1998, Functions of lipid rafts in biological membranes, Annu. Rev. Cell Dev. Biol., 14, 111, 10.1146/annurev.cellbio.14.1.111 · DOI
  16. Brown, 2000, Structure and function of sphingolipid- and cholesterol-rich membrane rafts, J. Biol. Chem., 275, 17221, 10.1074/jbc.R000005200 · DOI
  17. London, 2000, Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts), Biochim. Biophys. Acta, 1508, 182, 10.1016/S0304-4157(00)00007-1 · DOI
  18. Simons, 2000, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell Biol., 1, 31, 10.1038/35036052 · DOI · Paper page
  19. Fastenberg, 2003, Exclusion of a transmembrane-type peptide from ordered-lipid domains (rafts) detected by fluorescence quenching: extension of quenching analysis to account for the effects of domain size and domain boundaries, Biochemistry, 42, 12376, 10.1021/bi034718d · DOI
  20. Sprong, 2001, How proteins move lipids and lipids move proteins, Nat. Rev. Mol. Cell Biol., 2, 504, 10.1038/35080071 · DOI
  21. Sinicrope, 1992, Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles, J. Biol. Chem., 267, 24995, 10.1016/S0021-9258(19)73996-9 · DOI
  22. Regev, 1999, Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells, Eur. J. Biochem., 259, 18, 10.1046/j.1432-1327.1999.00037.x · DOI
  23. Czarny, 1999, Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin-182-101, J. Biol. Chem., 274, 2717, 10.1074/jbc.274.5.2717 · DOI
  24. Ohvo, 1996, Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate, Biochemistry, 35, 8018, 10.1021/bi9528816 · DOI
  25. Gimpl, 1997, Cholesterol as modulator of receptor function, Biochemistry, 36, 10959, 10.1021/bi963138w · DOI
  26. Bodin, 2001, Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation, Biochemistry, 40, 15290, 10.1021/bi0109313 · DOI
  27. Klein, 1995, Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor, Biochemistry, 34, 13784, 10.1021/bi00042a009 · DOI · Paper page
  28. Feller, 1995, Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry, Br. J. Cancer, 72, 543, 10.1038/bjc.1995.371 · DOI
  29. Klimecki, 1994, P-glycoprotein expression and function in circulating blood cells from normal volunteers, Blood, 83, 2451, 10.1182/blood.V83.9.2451.2451 · DOI
  30. Parasrampuria, 2001, A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function, Pharm. Res., 18, 39, 10.1023/A:1011070509191 · DOI
  31. Dantzig, 1999, Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities, J. Pharmacol. Exp. Ther., 290, 854
  32. Smart, 2002, Alterations in membrane cholesterol that affect structure and function of caveolae, Methods Enzymol., 353, 131, 10.1016/S0076-6879(02)53043-3 · DOI
  33. Pike, 2002, Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking, Biochemistry, 41, 10315, 10.1021/bi025943i · DOI
  34. Ehehalt, 2003, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol., 160, 113, 10.1083/jcb.200207113 · DOI · Paper page
  35. Rothnie, 2001, The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence, Eur. Biophys. J., 30, 430, 10.1007/s002490100156 · DOI
  36. Garrigues, 2002, The multidrug transporter, P-glycoprotein actively mediates cholesterol redistribution in the cell membrane, Proc. Natl. Acad. Sci. USA, 99, 10347, 10.1073/pnas.162366399 · DOI
  37. Kim, 2003, Drug transporters in HIV therapy, Top. HIV Med., 11, 136
  38. Schwab, 2003, Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis, Gastroenterology, 124, 26, 10.1053/gast.2003.50010 · DOI
  39. Arima, 2001, Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus, J. Pharmacol. Exp. Ther., 297, 547
  40. Yunomae, 2003, Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells, FEBS Lett., 536, 225, 10.1016/S0014-5793(03)00059-0 · DOI

Cited by

Sorted by citations

Metadata

Authors
Troost, J., Albermann, N., Emil Haefeli, W., & Weiss, J.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2004-04
Volume
316
Issue
3
Pages
705-711
ISSN
0006-291X
DOI
10.1016/j.bbrc.2004.02.102
Cited by
40
References
0
Language
en
Licence
Funders
Bundesministerium für Bildung und Forschung

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review